Patents by Inventor David J. Schneider

David J. Schneider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10497204
    Abstract: A method for tracking an event of an externally controlled interface (ECI) is described. The method includes generating the externally controlled interface independent of an outcome of a wager-based game regulated by a regulatory authority, and logging the event of the externally controlled interface.
    Type: Grant
    Filed: May 11, 2016
    Date of Patent: December 3, 2019
    Assignee: IGT
    Inventors: Reid M. Weber, William C. Little, Steven G. LeMay, Adrian R. Marcu, Warner R. Cockerille, IV, Nicole M. Beaulieu, David A. Gipp, Daniel de Waal, Vincent S. Manfredi, Bryan Bullard, Cara L. Iddings, Richard J. Schneider, Glenn Keith Russell, Jacob Graham, Gregory A. Schlottmann, Richard E. Rowe, David C. Williams, Kurt M. Larsen, Jae Man Yi, Erik B. Petersen
  • Publication number: 20190337478
    Abstract: An overhead mountable inflatable airbag assembly for a vehicle is disclosed. Inflatable airbag assemblies may provide protection for an occupant in a vehicle collision event. The disclosed airbag assembly may form a sideways V shape to be supported at the roof by an inflator, housing, or other mounting method, and at or near a lower (distal) end against a portion of an instrument panel or a rear portion of a forward occupant seat. The supported sideways V shape may support the occupant during ride down to provide protection of the occupant. The supported sideways V shape may also reduce the volume of inflation gas required to properly inflate the airbag assembly, and may reduce the overall packaged volume of the airbag assembly.
    Type: Application
    Filed: May 2, 2018
    Publication date: November 7, 2019
    Inventors: David W. Schneider, Frank J. Herzenstiel
  • Publication number: 20190321651
    Abstract: Stimulation of target cells using light, e.g., in vivo, is implemented using a variety of methods and devices. According to an example embodiment of the present invention, target cells are stimulated using an implantable arrangement. The arrangement includes an electrical light-generation means for generating light and a biological portion. The biological portion has a photosensitive bio-molecular arrangement that responds to the generated light by stimulating target cells in vivo.
    Type: Application
    Filed: May 6, 2019
    Publication date: October 24, 2019
    Inventors: Karl Deisseroth, Michael Bret Schneider, David J. Mishelevich
  • Publication number: 20190200597
    Abstract: One nonlimiting variation of a detection arrangement includes one or more sensors each structured to detect at least one biochemical substance indicative of biochemistry of one or more target insect species and provide a corresponding sensor signal, a controller responsive to the sensor signal of each of the one or more sensors to determine if the one or more insect species are present and generate a corresponding output signal, and an indicator responsive to the output signal to indicate the presence of the one or more insect species.
    Type: Application
    Filed: March 6, 2019
    Publication date: July 4, 2019
    Inventors: Paul W. Borth, Nailah Orr, Peter N. Scherer, Brian M. Schneider, Mike P. Tolley, Christopher J. Voglewede, Gary D. Crouse, David G. McCaskill, Kerrm Y. Yau, Edward L. Olberding, Joseph J. DeMark, Marc L. Fisher
  • Publication number: 20190201073
    Abstract: Various aspects of a generator, ultrasonic device, and method for estimating a state of an end effector of an ultrasonic device are disclosed. The ultrasonic device includes an electromechanical ultrasonic system defined by a predetermined resonant frequency, including an ultrasonic transducer coupled to an ultrasonic blade. A control circuit measures a complex impedance of an ultrasonic transducer, wherein the complex impedance is defined as Z g ? ( t ) = V g ? ( t ) I g ? ( t ) . The control circuit receives a complex impedance measurement data point and compares the complex impedance measurement data point to a data point in a reference complex impedance characteristic pattern. The control circuit then classifies the complex impedance measurement data point based on a result of the comparison analysis and assigns a state or condition of the end effector based on the result of the comparison analysis.
    Type: Application
    Filed: August 28, 2018
    Publication date: July 4, 2019
    Inventors: Cameron R. Nott, Foster B. Stulen, Fergus P. Quigley, John E. Brady, Gregory A. Trees, Amrita Singh Sawhney, Rafael J. Ruiz Ortiz, Patrick J. Scoggins, Kristen G. Denzinger, Craig N. Faller, Madeleine C. Jayme, Alexander R. Cuti, Matthew S. Schneider, Chad P. Boudreaux, Brian D. Black, Maxwell Rockman, Gregory D. Bishop, Frederick E. Shelton, IV, David C. Yates
  • Patent number: 10307702
    Abstract: A filter is treated with a reduced amount of a halo active aromatic sulfanomide compound of Formula (I): wherein R1, R2, R3, R4, and R5 are independently selected from hydrogen, COOR?, CON(R?)2, alkoxy, CN, NO2, SO3R?, halogen, substituted or unsubstituted phenyl, sulfonamide, halosulfonamide, and substituted or unsubstituted C1-C12 alkyl; R? is hydrogen, an alkali metal, an alkaline earth metal, substituted C1-C12 alkyl, or unsubstituted C1-C12 alkyl; and R? is hydrogen or substituted or unsubstituted C1-C12 alkyl, where the two R? groups in CON(R?)2 may be independently selected; X is halogen; M is an alkali or alkaline earth metal; and n is the number of water molecules per molecule of the sulfonamide compound. The compound effectively suppresses odors pre-use, in use, and post-use for extended periods of time.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: June 4, 2019
    Assignee: REM BRANDS, INC.
    Inventor: David J. Schneider
  • Patent number: 10297097
    Abstract: Methods, systems, and devices for reserving a reservable asset using a mobile device. A mobile device communicates directly with a vehicle-associated control module or through a reservation server using either a TCP/IP communications channel or near-field communications. A member enters a request using the user interface provided by the mobile-device application. The identity of the member is validated the vehicle-associated control module executes the request by sending a signal to a computer or sensor in the vehicle through the vehicle wiring or the vehicle CANbus. The request can be a function, such as unlocking the vehicle doors, illuminating the interior or exterior lights, honking the horn, or activating a panic alarm.
    Type: Grant
    Filed: June 8, 2010
    Date of Patent: May 21, 2019
    Assignee: ZIPCAR, INC.
    Inventors: Lesley Mottla, Douglas Williams, Jonathan Eric Wolfe, Gregory Ramsperger, David J. Goldman, Syed Naveed Ghalib, Lisa Rigano, Lucas P. Schneider
  • Publication number: 20180280563
    Abstract: Articles are treated with a reduced amount of a halo active aromatic sulfanomide compound of Formula (I): wherein R1, R2, R3, R4, and R5 are independently selected from hydrogen, COOR?, CON(R?)2, alkoxy, CN, NO2, SO3R?, halogen, substituted or unsubstituted phenyl, sulfonamide, halosulfonamide, and substituted or unsubstituted C1-C12 alkyl; R? is hydrogen, an alkali metal, an alkaline earth metal, substituted C1-C12 alkyl, or unsubstituted C1-C12 alkyl; and R? is hydrogen or substituted or unsubstituted C1-C12 alkyl, where the two R? groups in CON(R?)2 may be independently selected; X is halogen; M is an alkali or alkaline earth metal; and n is the number of water molecules per molecule of the sulfonamide compound. The compound effectively suppresses odors pre-use, in use, and post-use for extended periods of time.
    Type: Application
    Filed: June 5, 2018
    Publication date: October 4, 2018
    Inventors: David J. Schneider, Laura G. Kiely
  • Patent number: 9994448
    Abstract: Processes for extracting iodine from an aqueous solution, such as brine, are disclosed. Activated coconut carbon particles are mixed with the solution to adsorb iodide through pores in the activated carbon particles. The activated carbon particles are then treated with sulfur dioxide gas and water to form hydrogen iodide. The hydrogen iodide is then reacted with chloride to obtain elemental iodine (I2).
    Type: Grant
    Filed: November 12, 2009
    Date of Patent: June 12, 2018
    Assignee: IOFINA CHEMICAL, INC.
    Inventors: Charles A. Schneider, David J. Schneider
  • Patent number: 9987389
    Abstract: Articles are treated with a reduced amount of a halo active aromatic sulfonamide compound of Formula (I): wherein R1, R2, R3, R4, and R5 are independently selected from hydrogen, COOR?, CON(R?)2, alkoxy, CN, NO2, SO3R?, halogen, substituted or unsubstituted phenyl, sulfonamide, halosulfonamide, and substituted or unsubstituted C1-C12 alkyl; R? is hydrogen, an alkali metal, an alkaline earth metal, substituted C1-C12 alkyl, or unsubstituted C1-C12 alkyl; and R? is hydrogen or substituted or unsubstituted C1-C12 alkyl, where the two R? groups in CON(R?)2 may be independently selected; X is halogen; M is an alkali or alkaline earth metal; and n is the number of water molecules per molecule of the sulfonamide compound. The compound effectively suppresses odors pre-use, in use, and post-use for extended periods of time.
    Type: Grant
    Filed: February 9, 2016
    Date of Patent: June 5, 2018
    Assignee: REM BRANDS, INC.
    Inventors: David J. Schneider, Laura G. Kiely
  • Publication number: 20180125836
    Abstract: A method for inhibiting platelet aggregation in a patient in need thereof, comprising 1) administering to the patient a bolus injection of an active drug, in an amount of between about 25 ?g/kg, and 2) administering to the patient, after the bolus injection, an intravenous infusion for a period of between about 12 hours and about 72 hours, of the active drug, in an amount of about 0.15 ?g/kg/min, wherein the active drug is tirofiban or a salt thereof.
    Type: Application
    Filed: August 31, 2017
    Publication date: May 10, 2018
    Inventors: Peter M. DiBATTISTE, David J. SCHNEIDER
  • Publication number: 20170340998
    Abstract: A filter is treated with a reduced amount of a halo active aromatic sulfanomide compound of Formula (I): wherein R1, R2, R3, R4, and R5 are independently selected from hydrogen, COOR?, CON(R?)2, alkoxy, CN, NO2, SO3R?, halogen, substituted or unsubstituted phenyl, sulfonamide, halosulfonamide, and substituted or unsubstituted C1-C12 alkyl; R? is hydrogen, an alkali metal, an alkaline earth metal, substituted C1-C12 alkyl, or unsubstituted C1-C12 alkyl; and R? is hydrogen or substituted or unsubstituted C1-C12 alkyl, where the two R? groups in CON(R?)2 may be independently selected; X is halogen; M is an alkali or alkaline earth metal; and n is the number of water molecules per molecule of the sulfonamide compound. The compound effectively suppresses odors pre-use, in use, and post-use for extended periods of time.
    Type: Application
    Filed: August 11, 2017
    Publication date: November 30, 2017
    Inventor: David J. Schneider
  • Publication number: 20170027559
    Abstract: A system and method for soft tissue repair. According to one embodiment, sensing gauges or other sensing technologies are utilized at distal ends of jaws, passing a needle or within the instrument to identify tissue differences that give the end user feedback on these differences. A console connected to the instrument assists in utilizing sensing technology to give the end user feedback on tissue differences.
    Type: Application
    Filed: July 27, 2016
    Publication date: February 2, 2017
    Inventors: David J. Schneider, Eric P. Guyer
  • Patent number: 9408940
    Abstract: An odor-controlling bodily fluid absorbent member comprises (a) an absorbent material or substrate; and (b) a halo active aromatic sulfonamide compound of Formula (I): wherein R1, R2, R3, R4, R5, X, M, and n are as described herein; and wherein at least one of R1, R2, R3, R4, and R5 is not hydrogen. The absorbent member effectively controls odor arising from various body fluids.
    Type: Grant
    Filed: April 22, 2013
    Date of Patent: August 9, 2016
    Inventors: David J. Schneider, Charles A. Schneider
  • Publication number: 20160158404
    Abstract: Articles are treated with a reduced amount of a halo active aromatic sulfonamide compound of Formula (I): wherein R1, R2, R3, R4, and R5 are independently selected from hydrogen, COOR?, CON(R?)2, alkoxy, CN, NO2, SO3R?, halogen, substituted or unsubstituted phenyl, sulfonamide, halosulfonamide, and substituted or unsubstituted C1-C12 alkyl; R? is hydrogen, an alkali metal, an alkaline earth metal, substituted C1-C12 alkyl, or unsubstituted C1-C12 alkyl; and R? is hydrogen or substituted or unsubstituted C1-C12 alkyl, where the two R? groups in CON(R?)2 may be independently selected; X is halogen; M is an alkali or alkaline earth metal; and n is the number of water molecules per molecule of the sulfonamide compound. The compound effectively suppresses odors pre-use, in use, and post-use for extended periods of time.
    Type: Application
    Filed: February 9, 2016
    Publication date: June 9, 2016
    Inventors: David J. Schneider, Laura G. Kiely
  • Publication number: 20160120856
    Abstract: A method for inhibiting platelet aggregation in a patient in need thereof, comprising 1) administering to the patient a bolus injection of an active drug, in an amount of between about 25 ?g/kg, and 2) administering to the patient, after the bolus injection, an intravenous infusion for a period of between about 12 hours and about 72 hours, of the active drug, in an amount of about 0.15 ?g/kg/min, wherein the active drug is tirofiban or a salt thereof.
    Type: Application
    Filed: January 8, 2016
    Publication date: May 5, 2016
    Inventors: Peter M. DiBATTISTE, David J. SCHNEIDER
  • Patent number: 9040587
    Abstract: Aromatic N-halosulfonamide organic compounds have been known for over one hundred years. The ability of these compounds to release active halogen ions has been utilized in a range of biocidal and fungicidal applications. This disclosure deals with the use of halo active aromatic sulfonamide organic compounds as odor control and/or biocidal agents in a cleaning solution for use with bovines and other dairy animals.
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: May 26, 2015
    Inventors: David J. Schneider, Charles A. Schneider
  • Patent number: 8759399
    Abstract: Aromatic N-halosulfonamide organic compounds have been known for over one hundred years. The ability of these compounds to release active halogen ions has been utilized in a range of biocidal and fungicidal applications. This disclosure deals with the use of halo active aromatic sulfonamide organic compounds as odor control and/or biocidal agents in a cleaning solution for use with bovines and other dairy animals.
    Type: Grant
    Filed: August 17, 2011
    Date of Patent: June 24, 2014
    Inventors: David J. Schneider, Charles A. Schneider
  • Patent number: 8740913
    Abstract: Apparatuses are provided for arthroscopic rotator cuff repair incorporating a transhumeral bone tunnel. The apparatus comprises a number of components that can also be considered a repair system to include a drill guide, a marking hook, and a drill with a removable tip that serves as a bone anchor. In additional aspects of the invention, the components of the drill guide assembly comprise a cannulated marking hook and a drill guide with multiple bores. In additional aspects of the invention, an implantable bone anchor is provided that is especially adapted for placement through a bone tunnel, and wherein the implantable anchor is collapsible to increase the effective size of the anchor for securing the anchor to the far side opening of the bone tunnel through which the anchor was placed.
    Type: Grant
    Filed: December 6, 2011
    Date of Patent: June 3, 2014
    Assignee: Biomet Sports Medicine, LLC
    Inventor: David J. Schneider
  • Patent number: 8738144
    Abstract: Bioelectric implants are provided in three distinct embodiments, namely a bone/tissue anchor, a suture construction, and a plate. The bioelectric implants function in dual capacities as both fixation devices, and as galvanic cells for the production of electrical energy used for therapeutic purposes in tissue regeneration and healing. The bioelectric anchor may take the general form of a screw or pin having a hollow interior or cavity that extends through the body of the anchor. A coating can be applied to the cavity to form the anode portion of the galvanic cell. The outer surface of the anchor serves as a cathode. Bodily fluids and tissue act as an electrolyte to facilitate the chemical reactions necessary for the galvanic cell. For the suture construction, one or more strands of material are the cathode, and one or more strands of peripheral surrounding material act as the anode. Bodily fluids/tissue in contact with the suture act as an electrolyte.
    Type: Grant
    Filed: May 12, 2009
    Date of Patent: May 27, 2014
    Assignee: Ingenium, LLC
    Inventor: David J. Schneider